| BL/BLI | β-lactam/β-lactamase inhibitor |
| BSI | blood stream infections |
| CRE | carbapenem-resistant Enterobacteriales |
| CAZ/AVI | ceftazidime/avibactam |
| C/T | ceftolozane/tazobactam |
| cIAI | complicated intra-abdominal infections |
| cUTI | complicated urinary tract infections |
| DTR | difficult-to-treat resistance |
| ESBL | Extended-spectrum Beta-lactamase |
| GNB | Gram-negative bacteria |
| HAP | hospital acquired pneumonia |
| IMP | imipenemase |
| KPC | Klebsiella pneumoniae carbapenemases |
| MBL | metallo β-lactamases |
| MDR | multidrug resistant |
| NDM | new Delhi metallo beta-lactamase |
| PDR | pandrug resistant |
| NP | nosocomial pneumonia |
| OXA | oxacillinases |
| VAP | Ventilator associated pneumonia |
| VIM | Verona integron-borne metallo-β-lactamase |
| XDR | extensive drug resistance |